May 7 (Reuters) - GlaxoSmithKline Plc:
* GLAXOSMITHKLINE PLC - GSK SELLS ITS HOLDING IN HINDUSTAN UNILEVER
* GSK - AGREED TO SALE OF 133,772,044 ORDINARY SHARES IN HUL
* GSK - THROUGH MERGER OF GSK INDIA WITH HUL, GSK ACQUIRED A 5.7% STAKE IN HUL
* GSK - AGREED TO SALE OF 133,772,044 ORDINARY SHARES IN HUL AT A VOLUME-WEIGHTED AVERAGE PRICE OF APPROXIMATELY RS. 1,905 PER SHARE
* GSK - SALE AT A VOLUME-WEIGHTED AVERAGE PRICE OF APPROXIMATELY RS. 1,905 PER SHARE
* GSK - PROPOSED DEAL FOR GROSS PROCEEDS OF APPROXIMATELY RS. 254.8 BILLION
* GSK - NOW EXPECTS GROSS PROCEEDS FROM DIVESTMENT TO BE £3.4 BILLION
* GSK - GSK NOW EXPECTS GROSS PROCEEDS FROM DIVESTMENT TO BE £3.4 BILLION AND NET PROCEEDS FROM DIVESTMENT TO BE £2.9 BILLION
* GSK - PROPOSED DEAL FOLLOWING SETTLEMENT OF SALE, GSK WILL NO LONGER HOLD ANY HUL SHARES.
* GSK - HSBC SECURITIES AND CAPITAL MARKETS, J.P. MORGAN INDIA, MORGAN STANLEY INDIA ACTING AS JOINT PLACEMENT AGENTS FOR PLACING Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.